ScholarWorks@SOONCHUNHYANG UNIVERSITY: Lee, Chang ho

Detailed Information

Lee, Chang ho (이창호)

College of Medicine (Department fo Urology)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

prostate cancer:3||Transforming growth factor beta:2||prognosis:2||Urethra:2||Cell line:2||Cyr61:2||Urinary bladder neoplasms:2||Metaanalysis:2||Testosterone:2||ubiquitin:2||Fecal incontinence:1||Gene expression:1||Graciloplasty:1||Holmium:1||Hormone replacement therapy:1||Hypogonadism:1||IMMUNOHISTOCHEMISTRY:1||MAST CELL:1||Malignant:1||Mcl1:1||Mesothelioma:1||Metabolic syndrome:1||Microarray analysis:1||Midazolam:1||Nacetylcysteine:1||Pain measurement:1||Prooxidant:1||Prognosis:1||Prostate cancer:1||Prostate cancers:1||Prostate hyperplasia:1||Prostatespecific antigen:1||Qtip test:1||ROS:1||Resveratol:1||Retrograde urethrography:1||Sacral nerve stimulation:1||Sexual health:1||Sphincteroplasty:1||Stress urinary incontinence:1||Surgery:1||TOLUIDINE BLUE STAINING:1||TRANSITIONAL CELL CARCINOMA:1||TRYPTASE:1||Aged:1||Transurethral resection of prostate:1||UBE2C:1||UBE2O:1||USP11:1||Ubiquitin:1||Urethral catheterization:1||Urethral injury:1||Urinary incontinence:1||apoptosis:1||body mass index:1||fluorodeoxyglucose F18:1||gene silencing:1||invasion:1||migration:1||obesity:1||periprostatic adipose tissue:1||positron emission tomography:1||prostate carcinoma:1||prostatespecific antigen density:1||prostatic specific antigen:1||prostatic specific antigen density:1||receiver operating characteristic curve:1||TUMOUR GRADE:1||Antioxidants:1||Apoptosis:1||BLADDER NEOPLASM:1||BclxL:1||Biopsy:1||Cell survival:1||Clofarabine:1||Congenital abnormalities:1||Diverticulum:1||

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE